Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lohmann

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
European Journal of Pediatrics|June 26, 2012
Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literatureJan-Ulrich Schlump, Anja Stein, Ute Hehr, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2014
Autosomal recessive POLR1D mutation with decrease of TCOF1 mRNA is responsible for Treacher Collins syndromeElise Schaefer, Corinne Collet, David Genevieve, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma SurvivorsPetra Temming, Marina Arendt, Anja Viehmann, et al.
Pediatric Blood & Cancer|August 28, 2016
Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference centerPetra Temming, Marina Arendt, Anja Viehmann, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Journal of Genetic Syndromes & Gene Therapy|October 1, 2013
Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™Bw Downs, M Oscar-Berman, Rl Waite, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Transplantation Proceedings|March 20, 1999
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantationR Lohmann, J M Langrehr, J Klupp, et al.
European Journal of Pediatrics|June 26, 2012
Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literatureJan-Ulrich Schlump, Anja Stein, Ute Hehr, et al.
Clinical Transplantation|August 1, 1998
A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantationJ M Langrehr, M Glanemann, O Guckelberger, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2014
Autosomal recessive POLR1D mutation with decrease of TCOF1 mRNA is responsible for Treacher Collins syndromeElise Schaefer, Corinne Collet, David Genevieve, et al.
Transplantation Proceedings|June 24, 1998
A randomized trial comparing anti-interleukin-2 receptor antibody and placebo for immunosuppressive therapy after OLTJ M Langrehr, M Glanemann, A Schneller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma SurvivorsPetra Temming, Marina Arendt, Anja Viehmann, et al.
Pediatric Blood & Cancer|August 28, 2016
Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference centerPetra Temming, Marina Arendt, Anja Viehmann, et al.
Transplantation|June 27, 1997
A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantationJ M Langrehr, N C Nüssler, U Neumann, et al.
Journal of Genetic Syndromes & Gene Therapy|October 1, 2013
Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™Bw Downs, M Oscar-Berman, Rl Waite, et al.
Pageof 17